C-Reactive protein augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes

Cardiovascular Research

Volumn 56, Issue 1, 2002, Pages 86-92

  Ikeda, Uichi ^a   Maeda, Yoshikazu ^a   Yamamoto, Keiji ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytokines; Gene expression; Infection inflammation; Myocytes; Nitric oxide

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME INDUCTION; HEART MUSCLE CELL; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNTHESIS; WESTERN BLOTTING;

ANIMALS; C-REACTIVE PROTEIN; CARDIOMYOPATHY, DILATED; CELLS, CULTURED; ENZYME INHIBITORS; HUMANS; INTERLEUKIN-1; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE;

EID: 0036774255     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00496-0     Document Type: Article

References (48)

1. Lowenstein C.J., Snyder S.H. Nitric oxide, a novel biological messenger. Cell. 70:1992;705-707.
2. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-140.
3. Nathan C., Xie Q. Regulation of biosynthesis of nitric oxide. J Biol Chem. 269:1994;13725-13728.
4. Ikeda U., Shimada K. Nitric oxide and cardiac failure. Clin Cardiol. 20:1997;837-841.
5. Haywood G.A., Tsao P.S., von der Leyen H.E., et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 93:1996;1087-1094.
6. Habib F.M., Springall D.R., Davies G.J., et al. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 347:1996;1151-1155.
7. Worrall N.K., Lazenby W.D., Misko T.P., et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med. 181:1995;63-70.
8. Vejlstrup N.G., Bouloumie A., Boesgaard S., et al. Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure. J Mol Cell Cardiol. 30:1998;1215-1223.
9. Wildhirt S.M., Suzuki H., Wolf W.P., et al. S-Methylisothiourea inhibits inducible nitric oxide synthase and improves left ventricular performance after acute myocardial infarction. Biochem Biophys Res Commun. 227:1996;328-333.
10. Webb D.J., Muirhead G.J., Wulff M., et al. Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. J Am Coll Cardiol. 36:2000;25-31.
11. Fung H.L., Chong S., Kowaluk E., Hough K., Kakemi M. Mechanisms for the pharmacologic interaction of organic nitrates with thiols: existence of an extracellular pathway for the reversal of nitrate vascular tolerance by N-acteylcysteine. J Pharmacol Exp Ther. 245:1988;524-530.
12. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol. 33:2001;1897-1918.
13. Maseri A. Inflammation, atherosclerosis, and ischemic events: exploring the hidden side of the moon. New Engl J Med. 336:1997;1014-1016.
14. Libby P., Geng Y.J., Sukhova G.K., Simon D.I., Lee R.T. Molecular determinants of atherosclerotic plaque vulnerability. Ann NY Acad Sci. 811:1997;134-145.
15. Pasceri V., Yeh E.T. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation. 100:1999;2124-2126.
16. Ridker P.M., Rifai N., Clearfield M., et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. New Engl J Med. 344:2001;1959-1965.
17. Ueda S., Ikeda U., Yamamoto K., et al. C-reactive protein as a predictor of cardiac rupture after acute myocardial infarction. Am Heart J. 131:1996;857-860.
18. Kaneko K., Kanda T., Yamauchi Y., et al. C-reactive protein in dilated cardiomyopathy. Cardiology. 91:1999;215-219.
19. Pasceri V., Willerson J.T., Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 102:2000;2165-2168.
20. Pasceri V., Chang J., Willerson J.T., Yeh E.T. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation. 103:2001;2531-2534.
21. Ratnam S., Mookerjea S. The regulation of superoxide generation and nitric oxide synthesis by C-reactive protein. Immunology. 94:1998;560-568.
22. Arcoleo F., Milano S., D'Agostino P., et al. Effect of partially modified retro-inverso analogues derived from C-reactive protein on the induction of nitric oxide synthesis in peritoneal macrophages. Br J Pharmacol. 120:1997;1383-1389.
23. Yamamoto K., Ikeda U., Seino Y., et al. Regulation of Na,K-adenosine triphosphatase gene expression by sodium ions in cultured neonatal rat cardiocytes. J Clin Invest. 92:1993;1889-1895.
24. Kamitani T., Ikeda U., Muto S., et al. Regulation of Na,K-ATPase gene expression by thyroid hormone in rat cardiocytes. Circ Res. 71:1992;1457-1464.
25. 15N]nitrate in biological fluids. Anal Biochem. 126:1982;131-138.
26. Shimpo M., Ikeda U., Maeda Y., et al. Effects of aspirin-like drugs on nitric oxide synthesis in rat vascular smooth muscle cells. Hypertension. 35:2000;1085-1091.
27. Ikeda U., Ikeda M., Minota S., Shimada K. Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells. Circulation. 99:1999;1230-1235.
28. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-κ B/Rel in induction of nitric oxide synthase. J Biol Chem. 269:1994;4705-4708.
29. Ikeda U., Maeda Y., Kawahara Y., Yokoyama M., Shimada K. Angiotensin II augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. Circulation. 92:1995;2683-2689.
30. Henrich C.J., Simpson P.C. Differential acute and chronic response of protein kinase C in cultured neonatal rat heart myocytes to α1-adrenergic and phorbol ester stimulation. J Mol Cell Cardiol. 20:1988;1081-1085.
31. Yeh E.T.H., Anderson V., Pasceri V., Willerson J.T. C-reactive protein: linking inflammation to cardiovascular complications. Circulation. 104:2001;974-975.
32. Du Clos T.W. Function of C-reactive protein. Ann Med. 32:2000;274-278.
33. Cermak J., Key N.S., Bach R.R., et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 82:1993;513-520.
34. Kinugawa K., Shimizu T., Yao A., et al. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ Res. 81:1997;911-921.
35. Mellor H., Parker P.J. The extended PKC superfamily. Biochem J. 332:1998;281-292.
36. Sugden P.H., Clerk A. Cellular mechanisms of cardiac hypertrophy. J Mol Med. 76:1998;725-746.
37. Clerk A., Sugden P.H. Specific signaling from PKC isoforms to MAPK cascades. Circ Res. 89:2001;847-849.
38. Volanakis J.E., Narkates A.J. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement. J Immunol. 126:1981;1820-1825.
39. Man R.Y., Kinnaird A.A., Bihler I., Choy P.C. The association of lysophosphatidylcholine with isolated cardiac myocytes. Lipids. 25:1990;450-454.
40. Lagrand W.K., Niessen H.W., Wolbink G.J., et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation. 95:1997;97-103.
41. Pietila K.O., Harmoinen A.P., Jokiniitty J., Pasternack A.I. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J. 17:1996;1345-1349.
42. Nikfardjam M., Mullner M., Schreiber W., et al. The association between C-reactive protein on admission and mortality in patients with acute myocardial infarction. J Intern Med. 247:2000;341-345.
43. Anzai T., Yoshikawa T., Shiraki H., et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation. 96:1997;778-784.
44. Winlaw D.S., Smythe G.A., Keogh A.M., et al. Increased nitric oxide production in heart failure. Lancet. 344:1994;373-374.
45. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Engl J Med. 323:1990;236-241.
46. Satoh M., Nakamura M., Tamura G., et al. Inducible nitric oxide synthase and tumor necrosis factor-α in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol. 29:1997;716-724.
47. Francis S.E., Holden H., Holt C.M., Duff G.W. Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J Mol Cell Cardiol. 30:1998;215-223.
48. De Belder A.J., Radomski M.W., Why H.J.F., et al. Nitric oxide synthase activities in human myocardium. Lancet. 341:1993;84-85.